Dose response effects of lisdexamfetamine dimesylate treatment in adults with ADHD: An exploratory study

Journal of Attention Disorders

Volumn 16, Issue 2, 2012, Pages 118-127

  Faraone, Stephen V ^a   Spencer, Thomas J ^b   Kollins, Scott H ^c   Glatt, Stephen J ^a   Goodman, David ^d  

^a SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c DUKE UNIVERSITY   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

ADHD; amphetamine; dose response; lisdexamfetamine dimesylate; stimulants

Indexed keywords

CENTRAL STIMULANT AGENT; DEXAMPHETAMINE; LISDEXAMFETAMINE;

ADOLESCENT; ADULT; ARTICLE; ATTENTION DEFICIT DISORDER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG ADMINISTRATION; FEMALE; HUMAN; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; DEXTROAMPHETAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 84856014498     PISSN: 10870547     EISSN: 15571246     Source Type: Journal    
DOI: 10.1177/1087054711403716     Document Type: Article

References (23)

1. Adler L. A.,Goodman D. W.,Kollins S. H.,Weisler R. H.,Krishnan S.,Zhang Y.,Biederman J.Double-blind, placebo-controlled study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder.Journal of Clinical Psychiatry. 2008;69:1364-1373.
2. American Psychiatric Association 2000). Diagnostic and statistical manual of mental disorders (4th ed., text revision). Washington, DC: Author.Washington, DC: Author; 2000:.
3. Biederman J.,Boellner S. W.,Childress A.,Lopez F. A.,Krishnan S.,Zhang Y.Lisdexamfetamine dimesylate and mixed amphetamine salts extended-release in children with ADHD: A double-blind, placebo-controlled, crossover analog classroom study.Biological Psychiatry. 2007;62:970-976.
4. Biederman J.,Krishnan S.,Zhang Y.,McGough J. J.,Findling R. L.Efficacy and safety of lisdexamfetamine (LDX; NRP104) in children with attention-deficit/hyperactivity disorder: A phase 3, randomized, multicenter, double-blind, parallel-group study.Clinical Therapeutics. 2007;29:450-463.
5. Biederman J.,Lopez F. A.,Boellner S. W.,Chandler M. C.A randomized, double-blind, placebo-controlled, parallel-group study of SLI381 in children with attention deficit hyperactivity disorder.Pediatrics. 2002;110:258-266.
6. Colditz G. A.,Miller J. N.,Mosteller F.Measuring gain in the evaluation of medical technology. The probability of a better outcome.International Journal of Technology Assessment in Health Care. 1988;4:637-642.
7. Faraone S. V.Lisdexamfetamine dimesylate: The first long-acting prodrug stimulant treatment for attention deficit/hyperactivity disorder.Expert Opinion on Pharmacotherapy. 2008;9:1565-1574.
8. Faraone S. V.,Glatt S. J.A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes.Journal of Clinical Psychiatry. 2010;71:754-763.
9. Faraone S. V.,Sergeant J.,Gillberg C.,Biederman J.The worldwide prevalence of ADHD: Is it an American condition?.World Psychiatry. 2003;2:104-113.
10. Greenhill L. L.,Findling R. L.,Swanson J. M.A double-blind, placebo-controlled study of modified-release methylphenidate in children with attention-deficit/hyperactivity disorder.Pediatrics. 2002;109:E39.
11. Greenhill L. L.,Pliszka S.,Dulcan M. K.,Bernet W.,Arnold V.,Beitchman J.,... Kroeger K.Summary of the practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults.Journal of the American Academy of Child & Adolescent Psychiatry. 2001;40:1352-1355.
12. Guy W.Clinical global impressions in early clinical drug evaluation unit (ECDEU) assessment manual for psychopharmacology. Rockville, MD: National Institute of Mental Health Psychopharmacology Research Branch, US Department of Health, Education; 1976:.
13. Hanley J. A.,McNeil B. J.The meaning and use of the area under a receiver operating characteristic (ROC) curve.Radiology. 1982;143:29-36.
14. McGough J.,McCracken J.,Swanson J.,Riddle M.,Kollins S.,Greenhill L.,... Vitiello B.Pharmacogenetics of methylphenidate response in preschoolers with ADHD.Journal of the American Academy of Child & Adolescent Psychiatry. 2006;45:1314-1322.
15. McNeil B. J.,Hanley J. A.Statistical approaches to the analysis of receiver operating characteristic (ROC) curves.Medical Decision Making. 1984;4:137-150.
16. Mick E.,Faraone S. V.Genetics of attention deficit hyperactivity disorder.Child and Adolescent Psychiatric Clinics of North America. 2008;17:261 vii-284 viii.
17. Mick E.,Neale B.,Middleton F. A.,McGough J. J.,Faraone S. V.Genome-wide association study of response to methylphenidate in 187 children with attention-deficit/hyperactivity disorder.American Journal of Medical Genetics Part B: Neuropsychiatric Genetics. 2008;147B:1412-1418.
18. Spencer T.,Biederman J.,Wilens T.Pharmacotherapy of attention deficit hyperactivity disorder.Child and Adolescent Psychiatric Clinics of North America. 2000;9:77-97.
19. Swets J. A.Sensitivities and specificities of diagnostic tests.Journal of the American Medical Association. 1982;248:548-549.
20. Swets J. A.Form of empirical ROCs in discrimination and diagnostic tasks: Implications for theory and measurement of performance.Psychological Bulletin. 1986a;99:181-198.
21. Swets J. A.Indices of discrimination or diagnostic accuracy: Their ROCs and implied models.Psychological Bulletin. 1986b;99:110-117.
22. Swets J. A.,Pickett R. M.Evaluation of diagnostic systems: Methods from signal detection theory. New York, NY: Academic Press; 1982:.
23. Wolraich M.,Greenhill L. L.,Pelham W.,Swanson J.,Wilens T.,... Palumbo D.,August G.Randomized, controlled trial of oros methylphenidate once a day in children with attention-deficit/hyperactivity disorder.Pediatrics. 2001;108:883-892.